Virtual meeting
Via Zoom
Description
This training will cover the impact of hyperalgesia and cross tolerance on chronic pain among patients with opioid dependence and/or who are on medications for opioid use disorder. Pharmacological and non-pharmacological treatments for chronic pain management will be discussed. Participants will acquire tools for identifying pain severity and evaluating opioid use disorder in patients on chronic opioid therapy.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Pooja Lagisetty, MD, MSc (she/her)
Dr. Pooja Lagisetty is an Associate Professor at the University of Michigan Medical School and a research scientist at the Ann Arbor VA. She is the CoDirector of Research and Data Innovation in the University of Michigan Opioid Research Institute and Advance Fellowship in Addiction Research at the Ann Arbor VA. She is clinically boarded in both Internal Medicine and Addiction Medicine and cares for veterans within the Ann Arbor VA. Her research has been influential in understanding stigma and disparities for individuals with pain and addiction, comparing the effectiveness of treatments for opioid use disorder, and evaluating effects of opioid related policy.
Objectives
At the end of this training, participants will have the knowledge necessary to:
- Identify the impact of hyperalgesia and cross-tolerance on the chronic pain experience with patients on medications for opioid use disorder (MOUD) or with opioid dependence.
- Name at least two non-pharmacological and two adjunctive pharmacological treatments for chronic pain management.
- Implement the PEG scale to identify the severity of chronic pain appropriately.
- Evaluate symptoms of opioid use disorder (OUD) in patients on chronic opioid therapy.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,710,074.00 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Accreditation information
Please read the Accreditation Information section of the training page to learn about the requirements for receiving credit or a certificate of completion.
Audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
